Clinical Observation of “kuntai Formula”for the Treatment of Polycystic Ovary Syndrome

Qian Cao
2014-01-01
Abstract:Objective To observe the clinical efficacy ofKuntai Formulain treating polycystic ovary syndrome( PCOS). Methods One hundred and five subjects were randomized into two groups: treatment group in which 53 cases were treated withKuntai Formula,and control group in which 52 cases were treated with Ethinylestradiol and Cyproterone Acetate Tablets( Diane-35) orally,with a course of 3 months. The clinical efficacy was evaluated after treatment. The reproductive endocrinological indicators( FSH,LH,E2,PRL,testosterone,SHBG,leptin),body mass index( BMI) and waist-hip ratio( WHR) were compared before and after treatment. The rate of ovulation and pregnancy were compared between the two groups during the 3 months follow-up visit. Results ① Among 97cases,48 in treatment group and 49 in control group were finished the trial. ② The overall effective rate was 89. 6% in the treatment group and 73. 5% in the control group,with a difference between the two groups( P 0. 05). ③ After treatment,no significant difference was found in the levels of FSH,E2and PRL in both groups( P 0. 05); there were significant differences in the levels of LH,T,SHBG and Leptin in treatment group( P 0. 05); there were significant differences in the levels of LH and T in control group( P 0. 05),while without significant difference in SHBG level and Leptin level( P 0. 05). No significant difference was found in the levels of FSH,E2,PRL between the two groups( P 0.05); there were significant differences in SHBG level and Leptin level between the two groups,and the levels in treatment group was superior to control group( P 0. 05); there was significant difference in T level and LH level between the two groups( P 0. 05). ④ After treatment in treatment group,there was a significant difference in BMI( P 0. 05),but no significant difference in WHR( P 0. 05);in control group,no significant difference was found in BMI and WHR( P 0. 05). There was significant difference in BMI( P 0. 05),but no significant difference in WHR( P 0. 05) between the two groups. ⑤ During the 3 months' follow-up visit,the ovulation rate was 35. 4% and pregnancy rate was 16. 7% in treatment group; and was 6. 1% and 0% respectively in control group,with significant difference between the two groups( P 0. 05). Conclusion Kuntai Formulacan improve clinical symptoms,regulate reproductive endocrine hormone level and increase ovulation rate and pregnancy rate in PCOS.
What problem does this paper attempt to address?